X

Immuno-Oncology News

Immuno-Oncology News
Post-surgery Opdivo Shows Benefits for Esophageal, GEJ Cancer Patients in Ongoing Trial
Immuno-Oncology News
EMA to Review Opdivo-Yervoy Combo for Untreated, Inoperable Mesothelioma
Immuno-Oncology News
FDA Acts to Speed Toripalimab as Potential Nasopharyngeal Cancer Treatment
Immuno-Oncology News
EU Approval Recommended for Opdivo-Yervoy-Chemo Combo for Advanced NSCLC
Immuno-Oncology News
Tecentriq-Avastin Combo Recommended for EU Approval for Liver Cancer
Immuno-Oncology News
First-line Keytruda Doubles 5-Year Survival in Certain Lung Cancer Patients, Data Show
Immuno-Oncology News
Keytruda Combo Shown to Extend Survival in Advanced Esophageal, GEJ Cancers
Immuno-Oncology News
Libtayo First-line Treatment Prolongs Survival in Advanced NSCLC, Early Trial Data Show
Immuno-Oncology News
Strong Response for Tessa’s CD30 CAR-T Cell Therapy in Hodgkin’s Lymphoma Trial
Immuno-Oncology News
Subscribe to Immuno-Oncology News

source list reference

rgb(171, 222, 222)
#7d60d9
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
#352625
#4d4537
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
#d2093c
#8e3f1c
rgb(242, 0, 137)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
rgb (252, 186, 3)
#c61417
rgb(156, 242, 7)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(80, 147, 199)
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
#89f67c
#49a21d
rgb (132, 101, 173)
#2c990a
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
#a60538
rgb(2, 230, 230)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834